Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.73 |
| ▸ | LMNA | P02545 | 1/20 | 0.73 |
| ▸ | PRKCA | P17252 | 4/20 | 0.63 |
| ▸ | PRKCE | Q02156 | 2/20 | 0.63 |
| ▸ | PRKCQ | Q04759 | 2/20 | 0.63 |
| ▸ | PRKCD | Q05655 | 2/20 | 0.63 |
| ▸ | LPAR3 | Q9UBY5 | 7/20 | 0.60 |
| ▸ | LPAR1 | Q92633 | 4/20 | 0.60 |
| ▸ | ENPP2 | Q13822 | 3/20 | 0.60 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.60 |
| ▸ | LPAR2 | Q9HBW0 | 2/20 | 0.59 |
| ▸ | MAPT | P10636 | 1/20 | 0.57 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30597600 | 0.92 | ALDH1A1 (0.82) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL30531674 | 0.92 | ALDH1A1 (0.82) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL30531663 | 0.89 | ALDH1A1 (0.71) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL30531661 | 0.89 | ALDH1A1 (0.71) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL9462152 | 0.89 | ALDH1A1 (0.76) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL13519542 | 0.88 | PRKCA (0.61) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| Tripalmitin SCHEMBL27579952 | 0.86 | ALDH1A1 (0.82) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| Lactic Acid SCHEMBL27616620 | 0.86 | ALDH1A1 (0.82) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL24334742 | 0.85 | ALDH1A1 (1.00) | ALDH1A1LMNAPRKCAPRKCEPRKCQ | |
| SCHEMBL24333843 | 0.85 | ALDH1A1 (1.00) | ALDH1A1LMNAPRKCAPRKCEPRKCQ |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8653155-B2 | Polymers having lipophilic hydrocarbon and biodegradable polymeric segments | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2014-02-18 | — | — | US | disclosed |
| US-20110166249-A1 | POLYMERS HAVING LIPOPHILIC HYDROCARBON AND BIODEGRADABLE POLYMERIC SEGMENTS | BOSTON SCIENTIFIC SCIMED, INC. (US) | 2011-07-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110166249-A1 | POLYMERS HAVING LIPOPHILIC HYDROCARBON AND BIODEGRADABLE POLYMERIC SEGMENTS | LIPA, CETP, MGLL | ALDH1A1 2919/4885LMNA 115/4885PRKCA 3544/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.